International Patent: THERAPEUTIC VARIABLE DOMAIN OF HEAVY CHAIN (VHH) ANTIBODIES NEUTRALIZING INTERLEUKIN 13 (IL-13)

GENEVA, Aug. 31 -- MAX-PLANCK GESELLSCHAFT ZUR FÖRDERUNG DER WISSENSCHAFTEN E.V filed a patent application (EP2026/054133) for “THERAPEUTIC VARIABLE DOMAIN OF HEAVY CHAIN (VHH) ANTIBODIES NEUTRALIZING INTERLEUKIN 13 (IL-13)”. With publication no. WO/2026/175806, here are the other details related to the patent application:

Kind: Initial Publication with ISR [A1]

IPC: C07K 16/24

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Disclaimer: Curated by HT Syndication....